Basic Information
AtlasXomics is a developer of a spatial epigenomics technology platform aimed at providing multi-omics tissue maps. The company's platform leverages microfluidics and next-generation sequencing technologies to create transformative multi-omics maps of proteomics, transcriptomics, and epigenomics in tissues at cellular resolution, helping clinicians and researchers gain deep insights into interactions between cells.
AtlasXomics, Inc.
Connecticut,United States of America
15~50 people
January 01, 2020
info@atlasxomics.com
